COMMUNIQUÉS West-GlobeNewswire

Tempus Announces Latest Immunotherapy Project
15/11/2017
CHICAGO, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, along with Georgetown [...]
Scott VanderWel Joins PCI Synthesis as Business Development Manager
15/11/2017
NEWBURYPORT, Mass., Nov. 15, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. ( www.pcisynthesis.com ), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and [...]
HEALIOS Announces Enrollment of First Patient in Japan in TREASURE Study of MultiStem® Treatment for Ischemic Stroke
15/11/2017
CLEVELAND, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX ) announced today that its partner, HEALIOS K.K. (“Healios”), has enrolled the first patient in its study in Japan evaluating MultiStem ® cell [...]
Tabula Rasa HealthCare to Participate in the 29th Annual Piper Jaffray Healthcare Conference
15/11/2017
MOORESTOWN, N.J., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital [...]
Hemispherx Biopharma, Inc. CEO Interviewed on CEOLIVE.TV
15/11/2017
PHILADELPHIA, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), based in Philadelphia, focused on pharmaceuticals, today announced that Thomas K. Equels, M.S. J.D., Chief Executive [...]
Novartis, ASCP and ACS join forces to fight cancer in Ethiopia, Uganda and Tanzania
15/11/2017
Objective is to provide patients with rapid cancer diagnostics and appropriate care First focus will be on Ethiopia, Uganda and Tanzania Cancer is on the rise in Africa, with more than 500,000 deaths Basel, 15 November [...]
Immuron Granted US Patent for NASH Treatment
15/11/2017
MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), an Australian microbiome biopharmaceutical company focused on developing and commercialising oral immunotherapeutics for [...]
Zosano Pharma to Present at 29th Annual Piper Jaffray Healthcare Conference
15/11/2017
FREMONT, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Zosano Pharma Corp. (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical stage biopharmaceutical company focused on providing rapid systemic administration of [...]
CareDx Further Simplifies its Balance Sheet
15/11/2017
BRISBANE, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Progressive Care Reports Stellar Third Quarter Results
15/11/2017
MIAMI, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]
Accelerate Diagnostics to Present at the 29th Annual Piper Jaffray Healthcare Conference in New York City
15/11/2017
TUCSON, Ariz., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Lawrence Mehren, president and chief executive officer of Accelerate Diagnostics, is scheduled to present at the 29th Annual Piper Jaffray Healthcare Conference in New [...]
Skyline Medical and Helomics Corporation Sign Joint Venture Term Sheet to Build-out and Commercialize the D-CHIP™ platform
15/11/2017
MINNEAPOLIS, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]
Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Nine Months Ended September 30, 2017
15/11/2017
PHILADELPHIA, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE American:HEB) announced today its financial results for the third quarter ended September 30, 2017. The net loss was $1.3 million for the three [...]
Progressive Care Reports Stellar Third Quarter Results
15/11/2017
MIAMI, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]
Onconova Therapeutics Announces Publication of Results from Phase 1/2 Study of Rigosertib in Patients with Myelodysplastic Syndromes (MDS) and MDS Progressed to Acute Myeloid Leukemia
15/11/2017
Rigosertib reduced or stabilized bone marrow blasts and improved peripheral blood counts Patients with response or stable disease had one year longer survival than non-responders Rigosertib was well tolerated and a [...]
Abeona Reports Third Quarter 2017 Financial Results and Recent Business Highlights
15/11/2017
Investor Conference Call to be held Monday, November 20th at 10:00 am ET Global enrollment continues in ABO-102 trial for MPS IIIA Screening initiated in ABO-101 Phase 1/2 trial for MPS IIIB Pivotal Phase 3 planning [...]
ADMA Biologics Further Enhances Intellectual Property Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Compositions
15/11/2017
RAMSEY, N.J. and BOCA RATON, Fla., Nov. 15, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA ) is a vertically integrated biopharmaceutical and specialty immunoglobulin company that develops, manufactures and [...]
Medovex Corporation Initiates Move to List on the OTCQB Market
15/11/2017
ATLANTA, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Medovex Corp. (NASDAQ: MDVX ) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome [...]
Preclinical Studies with MyoKardia’s Mavacamten Demonstrate Evidence of Reduced Contractility and Improved Left Ventricular Compliance
15/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]

Pages